SEC Filings

Filing date	Form	Description	View
08/22/19	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-19-009798.pdf 0001179110-19-009798.rtf 0001179110-19-009798.xls
08/22/19	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-19-009796.pdf 0001179110-19-009796.rtf 0001179110-19-009796.xls
08/22/19	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-19-009800.pdf 0001179110-19-009800.rtf 0001179110-19-009800.xls
08/09/19	CT ORDER	CT ORDER	View HTML 9999999997-19-006419.pdf
08/05/19	10-Q	Quarterly report which provides a continuing view of a company's financial position	View HTML 0001558370-19-007084.pdf 0001558370-19-007084.rtf 0001558370-19-007084.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
07/31/19	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-19-042791.pdf 0001104659-19-042791.rtf 0001104659-19-042791.xls
07/03/19	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-19-008497.pdf 0001179110-19-008497.rtf 0001179110-19-008497.xls
06/18/19	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-19-036065.pdf 0001104659-19-036065.rtf 0001104659-19-036065.xls
06/14/19	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-19-035514.pdf 0001104659-19-035514.rtf 0001104659-19-035514.xls
06/07/19	3	Initial filing by director officer or owner of more than ten percent	View HTML 0001179110-19-007361.pdf 0001179110-19-007361.rtf 0001179110-19-007361.xls

Data provided by Kaleidoscope.

For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.